
Neoxone S 250mg/125mg Injection
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Neoxone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats a range of bacterial infections by inhibiting microbial growth and propagation. Administered solely by a healthcare provider, this injection requires adherence to the prescribed schedule. Complete the full course of treatment, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Seek immediate medical attention for worsening side effects or allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operation of vehicles if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration promote recovery. Your doctor may order blood tests and other diagnostic assessments to monitor treatment response.
Primary Ingredients of Neoxone S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Neoxone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Neoxone S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Neoxone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Neoxone S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
How Neoxone S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Neoxone S 250mg/125mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam's role as a beta-lactamase inhibitor safeguards Ceftriaxone's effectiveness by counteracting bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Neoxone S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Neoxone S 250mg/125mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Neoxone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Neoxone S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Operating a vehicle is contraindicated should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Neoxone S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Neoxone S 250mg/125mg Injection requires careful consideration in individuals with advanced hepatic impairment. A modified dosage of Neoxone S 250mg/125mg Injection may be necessary. Physician consultation is advised. Dosage alterations for Neoxone S 250mg/125mg Injection are generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Neoxone S 250mg/125mg Injection :
Omitting a scheduled dose of Neoxone S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Neoxone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
